Effectiveness of Kinesiotaping Along with Mulligan's Mobilization with Movement on Improving Pain and Function in Patients with Adhesive Capsulitis of Shoulder: a Randomized Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- King Saud University
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Visual Analogue Scale
Study Overview
Brief Summary
The study aimed to evaluate the effectiveness of combining Kinesiotaping with Mulligan's mobilization with movement in treating shoulder adhesive capsulitis. Thirty patients participated in a randomized control trial, divided equally into an experimental group and a control group. The experimental group received Kinesiotaping, Mulligan's mobilization with movement, and conventional physiotherapy, while the control group received only Mulligan's mobilization with movement and conventional physiotherapy. Pain, range of motion, and functional outcomes were measured using a visual analogue scale, goniometer, and the Shoulder Pain and Disability Index (SPADI) questionnaire.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Outcomes Assessor)
Eligibility Criteria
- Ages
- 40 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Primary adhesive capsulitis,
- •Controlled diabetes mellitus,
- •Restriction of movements in capsular pattern,
- •Shoulder pain for more than one month.
Exclusion Criteria
- •Secondary adhesive capsulitis,
- •Bilateral adhesive capsulitis,
- •Skin infections in the shoulder region,
- •Shoulder joint infections,
- •Wounds or ulcers in the shoulder region,
- •Hypersensitivity to tape,
- •Recent shoulder dislocation,
- •Recent shoulder fractures.
Arms & Interventions
Experimental Group
The experimental group received Kinesiotaping, Mulligan's mobilization with movement, and conventional physiotherapy.
Intervention: Kinesio taping (Other)
Experimental Group
The experimental group received Kinesiotaping, Mulligan's mobilization with movement, and conventional physiotherapy.
Intervention: Mulligan's mobilization with movement techniques (Other)
Experimental Group
The experimental group received Kinesiotaping, Mulligan's mobilization with movement, and conventional physiotherapy.
Intervention: Conventional physiotherapy (Other)
Control Group
Control group received only Mulligan's mobilization with movement and conventional physiotherapy
Intervention: Mulligan's mobilization with movement techniques (Other)
Control Group
Control group received only Mulligan's mobilization with movement and conventional physiotherapy
Intervention: Conventional physiotherapy (Other)
Outcomes
Primary Outcomes
Visual Analogue Scale
Time Frame: From enrollment to the end of treatment at 4 weeks
The Visual Analog Scale (VAS) is a tool for measuring subjective experiences, like pain. It's typically a 10 cm line, with endpoints marking the extremes (e.g., "no pain" to "worst imaginable pain"). The minimum value is 0, and the maximum is 10. Respondents mark a point on the line that corresponds to their experience. Higher scores usually indicate worse outcomes for negative experiences like pain.
Range of motion
Time Frame: From enrollment to the end of treatment at 4 weeks
Range of motion (ROM) measures the movement extent of a joint or body part, expressed in degrees. Minimum values indicate restricted movement (e.g., 0° signifies no movement), while maximum values represent full movement capacity (e.g., 180° for shoulder flexion). Higher scores generally indicate a better outcome, as they reflect greater flexibility and joint function.
Shoulder Pain and Disability Index
Time Frame: From enrollment to the end of treatment at 4 weeks
The Shoulder Pain and Disability Index (SPADI) is a 13-item questionnaire assessing pain and disability due to shoulder issues. Scores range from 0 to 100, with 0 indicating no pain/disability and 100 indicating severe pain/disability. Higher scores signify worse outcomes, reflecting greater pain and functional impairment.
Secondary Outcomes
No secondary outcomes reported
Investigators
Masood Khan
Principal Investigator
King Saud University